Jazz Pharmaceuticals, plc · Palo Alto, CA United States (NASDAQ: JAZZ)
| 3180 Porter Dr. | Phone: 650-496-3777 |
| Palo Alto, CA | Fax: 650-496-3781 |
| 94304 | |
| United States | 
Map This Company |
Jazz Pharmaceuticals, plc Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Jazz Pharmaceuticals is anything but free-form or improvisational in its development of drugs to treat psychiatric and neurological conditions. The company markets a treatment for narcolepsy under the name Xyrem and a treatment for social anxiety and obsessive compulsive disorder (OCD) under the name Luvox CR. Jazz Pharmaceuticals has license and supply agreements with
Jazz Pharmaceuticals, plc Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: JAZZ Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 242 |
Executives
53 executives listed for Jazz Pharmaceuticals, plc's Palo Alto, CA location.
| Chairman and CEO | Bruce Cozadd | |
|---|---|---|
| SVP and CFO | Kathryn Falberg | |
| SVP Chief Regulatory Officer and Chief Compliance Officer | Janne Wissel |